Factbox: Countries rush to buy antiviral COVID pills

1 minute read

A shopper wearing a protective face mask walks on Oxford Street, as rules on wearing face coverings in some settings in England are relaxed, amid the spread of the coronavirus disease (COVID-19) pandemic, in London, Britain, January 27, 2022. REUTERS/Toby Melville

Register now for FREE unlimited access to Reuters.com

Jan 28 (Reuters) - Countries are scrambling to buy the antiviral pills developed by Merck (MRK.N) and Pfizer (PFE.N) for adult COVID-19 patients.

The European Medicines Agency on Jan. 27 gave the green light to use Pfizer's antiviral COVID-19 pill for treating adults at risk of severe illness. read more

The regulator expects to give a final ruling on Merck's molnupiravir by the end of February. read more

Register now for FREE unlimited access to Reuters.com

On Friday, India's Dr.Reddy's Labs said it had started commercial production of a generic version of Merck's treatment.

Egypt, which approved Merck's COVID pill on Jan. 25, said the drug will be produced locally.

Here is an alphabetical list of other countries and their orders:

($1 = 85.4800 taka)

Register now for FREE unlimited access to Reuters.com
Reporting by Ina Kreutz, Agnieszka Gosciak and Federica Urso; Editing by Milla Nissi and Philippa Fletcher

Our Standards: The Thomson Reuters Trust Principles.